Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Reviewing
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • Clinical Oncology
      • Immuno-oncology
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Discovery
Cancer Discovery

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Reviewing
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • Clinical Oncology
      • Immuno-oncology
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
    • Journal Press Releases
Research Briefs

Naive T cell deficits at diagnosis and after chemotherapy impair cell therapy potential in pediatric cancers

Rajat K Das, Lauren Vernau, Stephan A. Grupp and David M. Barrett
Rajat K Das
Children's Hospital of Philadelphia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lauren Vernau
Immunotherapy, Children's Hospital of Philadelphia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephan A. Grupp
Division of Oncology, Children's Hospital of Philadelphia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David M. Barrett
Division of Oncology, Children's Hospital of Philadelphia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: barrettd@email.chop.edu
DOI: 10.1158/2159-8290.CD-18-1314
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Additional Files

  • Supplementary Data

    • Supplementary Data - All supplementary data
PreviousNext
Back to top

Published OnlineFirst January 10, 2019
doi: 10.1158/2159-8290.CD-18-1314

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Discovery article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Naive T cell deficits at diagnosis and after chemotherapy impair cell therapy potential in pediatric cancers
(Your Name) has forwarded a page to you from Cancer Discovery
(Your Name) thought you would be interested in this article in Cancer Discovery.
Citation Tools
Naive T cell deficits at diagnosis and after chemotherapy impair cell therapy potential in pediatric cancers
Rajat K Das, Lauren Vernau, Stephan A. Grupp and David M. Barrett
Cancer Discov January 10 2019 DOI: 10.1158/2159-8290.CD-18-1314

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Naive T cell deficits at diagnosis and after chemotherapy impair cell therapy potential in pediatric cancers
Rajat K Das, Lauren Vernau, Stephan A. Grupp and David M. Barrett
Cancer Discov January 10 2019 DOI: 10.1158/2159-8290.CD-18-1314
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • BCL2 Gly101Val Causes Resistance to Venetoclax in CLL
  • Afatinib in ERBB2-Amplified Gastric Cancer
  • BRCA Reversion Mutations and Resistance to PARP Inhibitor
Show more Research Briefs
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • OnlineFirst
  • Current Issue
  • Past Issues

Info For

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Discovery

  • About the Journal
  • Editors
  • Journal Sections
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2019 by the American Association for Cancer Research.

Cancer Discovery
eISSN: 2159-8290
ISSN: 2159-8274

Advertisement